ENTITY
SK Bioscience

SK Bioscience (302440 KS)

165
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
Refresh
bearishSK Bioscience
03 Jul 2024 11:55

Block Deal Prospects Arising from SK Group's Corporate Reshuffle

SK Group seems to have chosen a block deal of SK Innovation's stake in SKIET as the first step to improve SK On's financial structure. SK...

Logo
933 Views
Share
bullishSK Bioscience
30 Jun 2024 01:51

SK Bioscience (302440 KS): Acquiring Majority Stake in IDT Biologika- A Step Toward ‘Globalization’

SK Bioscience secures 60% stake in IDT Biologika, a global CDMO company with state-of-the-art manufacturing facilities in Germany, for KRW339B...

Logo
347 Views
Share
bullishSK Bioscience
27 Nov 2021 06:44

The Highly Mutated Omicron COVID Variant - Onset of the Dark Winter?

There has been a new, highly mutated COVID variant found in South Africa named Omicron by the WHO. In this insight, we will provide further details...

Logo
531 Views
Share
bullishSK Bioscience
28 Oct 2023 18:09

SK Bioscience (302440 KS): Significantly Improved 3Q Result Benefitted From One-Time Payment

In 3Q23, revenue jumped 2.5x YoY and 12.1x QoQ to KRW232B, mainly due to the inflow related to Novavax vaccine contract settlement, resumption of...

Logo
462 Views
Share
bullishSK Bioscience
14 Sep 2023 19:42

SK Bioscience (302440 KS): Flu Vaccine Output Resumes; Next-Gen Typhoid Vaccine Is On Card

SK Bioscience began first shipment of flu vaccine, SKYCellflu for 2023–24 flu season after a gap of three years. The company has entered agreement...

Logo
423 Views
Share
x